INTERIM STUDY COMMITTEE ON PUBLIC HEALTH, BEHAVIORAL HEALTH, AND HUMAN SERVICES

INTERIM STUDY COMMITTEE ON PUBLIC HEALTH, BEHAVIORAL HEALTH, AND HUMAN SERVICES 

THE COMMITTEE IS CHARGED WITH STUDYING THE FOLLOWING TOPICS:

(A)Factors contributing to the growth of health care costs, including the following:

(i) The current trends in health care delivery and Indiana's progress in implementing new approaches, including value-based medicine and other alternative payment models.

(ii) Access to health care in rural areas.

(iii) The impact of Indiana's poor health status, the social determinates of health, and the rate of the uninsured on health care costs.(Source: Letter from Rep. Kirchhofer; Rep. Carbaugh; Rep. Shackleford; Rep.Austin; Sen. Ruckelshaus; Sen.Bassler; and Sen. Spartz.)

(B)Prescription drug pricing and access, including the following:

(i) The process in which a prescription drug moves through the supply chain to the consumer, including the role of pharmaceutical manufacturers,wholesale distributors, pharmacies, specialty pharmacies, health insurers,and pharmacy benefit managers.

(ii) The methods that health insurers and pharmacy benefit managers currently use to manage prescription drug costs.

(iii) The function of pharmaceutical manufacturer rebates and discounts used by health insurers and pharmacy benefit managers to decrease the cost of a prescription drug for a consumer.

(iv) The current trends in health care spending in the United States,including prescription drug spending.

(v) The trends in insurance benefit design and the potential impact that changes are having or may have on consumer out-of-pocket costs for prescription drugs.

(vi) The efforts that pharmaceutical manufacturers, health insurers, and pharmacy benefit managers have made to be transparent about the following:

(a) Prescription drug costs.

(b) Utilization management methods, including drug formulary

changes, prior authorization, and step therapy requirements. (Source: SEA 176-2019.)(C)The following:(i) The advantages, disadvantages, and feasibility of requiring health care providers to issue prescriptions in an electronic format and by electronic transmission(ii) Any exceptions that would be needed to a requirement for health care providers to issue prescriptions in an electronic format and by electronic transmission.(Source: HEA 1029-2019.)

(D)Regulation and practices of pharmacy benefit managers. (Source:HEA 1588-2019.)

(E)Authorization of an advance practice registered nurse to operate without a practice agreement with a physician or certain other practitioners. (Source: SB 394-2019(as printed February 8, 2019); SB 343-2019 (as introduced).)

(F)The following hospital licensure issues:(i) A review of Indiana's current hospital licensing structure.(ii) Information concerning other states' hospital licensure and nationaltrends.(iii) Information concerning the different types of hospitals and possibleclassifications, including subclassifications, of these hospitals through thehospital's license.(vi) An examination of state hospital licensure in the context of federallaw, regulations, policies, and conditions of participation in the Medicareand Medicaid programs.(Source: SEA 575-2019.)

(G)Adoption subsidies. (Source: Letter from Senator Niezgodski